BG Medicine Inc
BG Medicine, Inc., a diagnostics company, engages in the development and commercialization of novel cardiovascular diagnostic tests to address unmet medical needs in the United States, Europe, and internationally. It offers BGM Galectin-3 test, a novel diagnostic test that measures galectin-3 in blood plasma or serum; and CardioSCORE test that is designed to identify cardiovascular events, such a… Read more
BG Medicine Inc (BGMD) - Total Assets
Latest total assets as of December 2015: $2.13 Million USD
Based on the latest financial reports, BG Medicine Inc (BGMD) holds total assets worth $2.13 Million USD as of December 2015.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
BG Medicine Inc - Total Assets Trend (2004–2015)
This chart illustrates how BG Medicine Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
BG Medicine Inc - Asset Composition Analysis
Current Asset Composition (December 2015)
BG Medicine Inc's total assets of $2.13 Million consist of 91.5% current assets and 8.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 71.5% |
| Accounts Receivable | $181.00K | 8.5% |
| Inventory | $145.00K | 6.8% |
| Property, Plant & Equipment | $11.00K | 0.5% |
| Intangible Assets | $77.00K | 3.6% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2004–2015)
This chart illustrates how BG Medicine Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BG Medicine Inc's current assets represent 91.5% of total assets in 2015, an increase from 72.7% in 2004.
- Cash Position: Cash and equivalents constituted 71.5% of total assets in 2015, up from 56.0% in 2004.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 0.0% in 2004.
- Asset Diversification: The largest asset category is accounts receivable at 8.5% of total assets.
BG Medicine Inc Competitors by Total Assets
Key competitors of BG Medicine Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
OJsys Inc
PINK:OJSY
|
USA | $8.03 Million |
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
BG Medicine Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - BG Medicine Inc generates 0.73x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - BG Medicine Inc is currently not profitable relative to its asset base.
BG Medicine Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.65 | 1.06 | 7.97 |
| Quick Ratio | 1.53 | 0.97 | 7.96 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $771.00K | $ 272.00K | $ 32.31 Million |
BG Medicine Inc - Advanced Valuation Insights
This section examines the relationship between BG Medicine Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -59.2% |
| Total Assets | $2.13 Million |
| Market Capitalization | $831.08 USD |
Valuation Analysis
Below Book Valuation: The market values BG Medicine Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: BG Medicine Inc's assets decreased by 59.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for BG Medicine Inc (2004–2015)
The table below shows the annual total assets of BG Medicine Inc from 2004 to 2015.
| Year | Total Assets | Change |
|---|---|---|
| 2015-12-31 | $2.13 Million | -59.21% |
| 2014-12-31 | $5.23 Million | -44.09% |
| 2013-12-31 | $9.35 Million | -38.63% |
| 2012-12-31 | $15.24 Million | -41.63% |
| 2011-12-31 | $26.11 Million | +271.57% |
| 2010-12-31 | $7.03 Million | -44.34% |
| 2009-12-31 | $12.62 Million | -64.15% |
| 2008-12-31 | $35.22 Million | +470.87% |
| 2006-12-31 | $6.17 Million | +98.81% |
| 2005-12-31 | $3.10 Million | -53.54% |
| 2004-12-31 | $6.68 Million | -- |